Clinical Trial Update: Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Skeletal Targeted Radiotherapy (STR) plus melphalan with stem cell transplant versus melphalan alone in multiple myeloma; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• Skeletal Targeted Radiotherapy

Snippet

Sponsor: Poniard Pharmaceuticals | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED